Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

ALC-0159

SKU: orb1298046

Description

ALC-0159 is a PEGylated lipid conjugate employed as a vaccine excipient. It is utilized in lipid nanoparticle (LNP) formulations for both in vitro and in vivo research, particularly in mRNA vaccine delivery and immunology studies.

Research Area

Metabolism Research

Images & Validation

Key Properties

CAS Number1849616-42-7
MW542.934
Puritypolymer
Formula(C2H4O)nC31H63NO2
SMILESN.CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(=O)COCCOC
TargetLiposome,Others
Solubility10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL;DMSO:117.5 mg/mL

Bioactivity

In Vitro
ALC-0159 promotes nanoparticle stabilization by a steric mechanism through its poly(ethylene glycol) (PEG) moiety.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

conjugate, ALC0159, ALC-0159, ALC 0159, inhibit, lipid, Inhibitor, excipient, vaccine

Similar Products

  • ALC-0307 [orb3033136]

    >95%

    863.5

    C55H110O4N2

    25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

5 mg
$ 100.00
10 mg
$ 130.00
25 mg
$ 200.00
50 mg
$ 320.00
100 mg
$ 460.00
200 mg
$ 660.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry